Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Sudipto Mukherjee
- Target Recruit Count
- 35
- Registration Number
- NCT03844997
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
News
No news found